New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn BPC 157 erectile dysfunction study: what the current evidence actually shows Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC